Status:
COMPLETED
Validity, Reliability and Minimum Detectable Changes of 2-Minute Walk , Timed Up and Go, Sit and Stand Test in Patients With Prostate Cancer
Lead Sponsor:
Acibadem University
Conditions:
Prostate Cancer
Eligibility:
MALE
55-75 years
Brief Summary
Prostate cancer is a type of cancer that can occur in men, especially in the fifth and sixth decades of their lives, and various side effects occur depending on the treatments applied in the diagnosed...
Detailed Description
Performance-based outcome measures are gaining importance in terms of patients' health care. These tests are not specific for any disease or extremity. They are specific tests for walking and getting ...
Eligibility Criteria
Inclusion
- Receiving or continuing Androgen deprivation therapy for at least 3 months
- Diagnosed with non-metastatic prostate cancer
- In the process of radiotherapy or chemoradiotherapy
- Able to walk without assistive device
- Patients over 55 years of age
Exclusion
- Diagnosed with metastatic prostate cancer
- Uncontrollable cardiovascular disease Uncontrollable insulin due to diabetes Individuals with neuromuscular, metabolic disease that may effect physical tests
Key Trial Info
Start Date :
February 20 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 20 2022
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT05195190
Start Date
February 20 2022
End Date
October 20 2022
Last Update
December 28 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Acıbadem Mehmet Ali Aydınlar University
Istanbul, Turkey (Türkiye)